dc.contributor.author | Vilborg Þ Sigurðardóttir 1968- | en |
dc.date.accessioned | 2008-08-11T10:28:13Z | |
dc.date.available | 2008-08-11T10:28:13Z | |
dc.date.issued | 2005 | en |
dc.identifier.isbn | 91-628-6582-X | en |
dc.identifier.uri | http://hdl.handle.net/2077/16630 | |
dc.subject | atherosclerosis | en |
dc.subject | ultrasound | en |
dc.subject | C-reactive protein | en |
dc.subject | oxidized low-density lipoprotein | en |
dc.subject | metabolic syndrome | en |
dc.subject | type 2 diabetes | en |
dc.subject | carotid artery | en |
dc.subject | femoral artery | en |
dc.subject | intima-media-thickness | en |
dc.subject | plaque | en |
dc.subject | echogenicity | en |
dc.subject | risk factors | en |
dc.title | The role of oxidized LDL and inflammation in the metabolic syndrome, diabetes and atherosclerosis | en |
dc.type | Text | en |
dc.type.svep | Doctoral thesis | en |
dc.gup.origin | Göteborgs universitet/University of Gothenburg | eng |
dc.gup.department | The Cardiovascular Institute / Wallenberg Laboratory | eng |
dc.gup.department | Hjärt-kärlinstitutionen / Wallenberglaboratoriet | swe |
dc.gup.defenceplace | Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg, kl. 13.00 | en |
dc.gup.defencedate | 2005-09-29 | en |
dc.gup.dissdbid | 6586 | en |
dc.gup.dissdb-fakultet | SA | |